ROVI reports operating revenue growth of 31% and net profit growth of 58%
3 min
27 Jul, 2022
EIB and ROVI are signing a EUR 50 million loan agreement in Madrid for research, development and innovation.
4 min
19 Jul, 2022
ROVI reports operating revenue growth of 57% and net profit growth of 123%
2 min
11 May, 2022
Moderna and ROVI Pharma Industrial Services, S.A.U. today announced a recall of one lot (lot #000190A) of the Moderna...
2 min
08 Apr, 2022
The achievement of this important milestone responds to the Environmental and Social Sustainability Policy of the Group...
3 min
04 Mar, 2022
ROVI reports operating revenue growth of 54% and net profit growth of 151%
2 min
23 Feb, 2022
Long-term agreement includes a series of investments to acquire new equipment and adapt the present ROVI drug product...
2 min
16 Feb, 2022
Risperidone ISM® is a prolonged-release injectable antipsychotic developed and patented by ROVI for the treatment of...
3 min
15 Feb, 2022
The funding is for the project "Evaluation of chronic toxicity in Risperidone ISM® Quarterly".
1 min
28 Jan, 2022